Considering the known anabolic effects of IGF-I and insulin on bone and periosteal expansion, it can be expected that the altered insulin–IGF-I–growth hormone axis (lower bioavailability of IGF-I) may also contribute to the observed geometrical alterations observed in inadequately controlled diabetes, as a lack of periosteal apposition and bone repair. Here, INS is linked to diabetes mellitus.